SCHEMBL5777596

SCHEMBL5777596

CON(C)C(=O)c1ccnc(N2CCN(C)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 1/20 0.46
PIK3CA P42336 2/20 0.45
DYRK1A Q13627 15/20 0.45
WNT1 P04628 6/20 0.43
GSK3B P49841 3/20 0.43
CLK2 P49760 3/20 0.42
CLK3 P49761 3/20 0.42
CLK4 Q9HAZ1 2/20 0.42
DYRK3 O43781 1/20 0.42
CSNK1E P49674 1/20 0.42
CLK1 P49759 1/20 0.42
CDK5 Q00535 1/20 0.42
CDK5R1 Q15078 1/20 0.42
DYRK2 Q92630 1/20 0.42
DYRK4 Q9NR20 1/20 0.42
DYRK1B Q9Y463 1/20 0.42
USP2 O75604 1/20 0.41
ALDH1A1 P00352 1/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL305261 0.86 PIK3CA (0.64) PIK3CADYRK1AWNT1GSK3BALDH1A1
SCHEMBL5775896 0.81 RAB9A (0.50) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL12639902 0.79 HRH4 (0.54) HRH4PIK3CADYRK1AWNT1GSK3B
SCHEMBL20951481 0.79 PIK3CA (0.68) HRH4PIK3CADYRK1AWNT1GSK3B
SCHEMBL20967224 0.78 HRH4 (0.52) HRH4PIK3CADYRK1AWNT1GSK3B
Hydrochloric Acid SCHEMBL20951268 0.78 PIK3CA (0.67) HRH4PIK3CADYRK1AWNT1GSK3B
SCHEMBL7887377 0.78 KDM4E (0.55) HRH4PIK3CADYRK1AWNT1GSK3B
SCHEMBL24269753 0.77 HDAC3 (0.50) HRH4USP2ALDH1A1CYP1A2CYP3A4
SCHEMBL7887400 0.76 DYRK1A (0.59) DYRK1AWNT1GSK3BCLK2CLK3
SCHEMBL1516956 0.75 PIK3CA (0.75) HRH4PIK3CADYRK1AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060276433-A1 Hydrazone derivative DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-12-07 US disclosed
EP-1612204-A1 HYDRAZONE DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2006-01-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276433-A1 Hydrazone derivative APP, PRNP, HTT HRH4 38/4885PIK3CA 4848/4885DYRK1A 4185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.